New technology that allows a University of Virginia-developed artificial pancreas system to adapt to users’ changing bodies – and lets users test changes to how the system operates – improved control ...

Diabetes management technology pioneer Beta Bionics has achieved another milestone, successfully amassing $100 million in its latest Series D equity funding round. The recent accomplishment surpasses ...

Mere weeks after announcing the first insulin pump partner for its FreeStyle Libre 2 Plus continuous glucose monitor—in which the “Plus” designates an FDA-cleared ability to link up with automated ...

The new iLet Bionic Pancreas system was cleared by the FDA for patients 6 and older with type 1 diabetes, the agency announced Friday. The pocket-sized system features the the Beta Bionics iLet ACE ...

Researchers will soon undertake one of the largest-ever long-term clinical trials of a system designed to help regulate blood sugar levels of individuals with type 1 diabetes mellitus. If the ...

The findings, said the researchers, are an important step toward achieving glucose control with a fully automated closed-loop system for patients with type 1 diabetes. For the first time, researchers ...

Four studies backed by the National Institutes of Health have either launched or are poised to launch in the near future. Researchers hope these studies will serve as the potential bridge between ...

New digital twin technology that allows a University of Virginia-developed artificial pancreas system to adapt to users’ changing needs – and lets users adjust the settings – has been shown to improve ...

After a year in development, Abbott is making its Freestyle Libre 3 blood sugar sensor available in the U.K. as part of an automated insulin delivery system for people with Type 1 diabetes. When ...

Please provide your email address to receive an email when new articles are posted on . The iLet bionic pancreas system conferred an average glucose of less than 183 mg/dL in 97% of adults with type 1 ...

Scientists have used an "artificial pancreas" system of pumps and monitors to improve blood sugar control in diabetes patients in the first study to show the new device works better than conventional ...